A baby who is part of a TB vaccine trial at the SATVI facility in Worcester, South Africa.

African scientists, institutions and communities are helping advance the development of new TB vaccines. Governments must now work together to prepare national systems, secure fair pricing and ensure scientific progress leads to timely and equitable access.

When I visited the University of Cape Town Lung Institute and the South African Tuberculosis Vaccine Initiative (SATVI) in May, I saw African scientific excellence at work.

Researchers showed us how new screening tools, mobile technologies and advances in diagnosis are bringing TB services closer to communities. We also heard about the progress being made across the TB vaccine pipeline, including candidates that could become the first new TB vaccines in more than a century and offer protection to adolescents and adults.

I left Cape Town encouraged by the science, but concerned by the gap between scientific progress and government preparation.

We have seen this happen before. A new health tool becomes available, but countries are not ready to approve it, finance it, procure it or deliver it. Years are then lost between scientific success and access for the people and communities who need it most.

Africa cannot afford to repeat that mistake.

Developers and manufacturers are already preparing for the possibility that one or more TB vaccine candidates will succeed. Manufacturing partnerships, technology transfer and production planning are beginning before final trial results are known.

This is responsible preparation. Manufacturing capacity takes time to build. Supply chains take time to establish. Regulatory processes take time to complete.

Governments must apply the same logic. Africa is not standing on the sidelines of this scientific effort. African scientists, health workers, research institutions, communities and people participating in clinical trials are helping advance the development of new vaccines.

Political leadership must now match that scientific leadership.

SATVI Associate Professor Angelique Kany Kany Luabeya, investigator on the M72 investigational TB vaccine study, told the visting MPs that for the first time in over a century there is reason for real optimism.

What African governments must do now

At our meeting in Cape Town, parliamentary Health and Finance Committee leaders from 14 African countries discussed what vaccine readiness would require.

We agreed that this could no longer be treated as a future conversation. Governments must begin preparing before final trial results arrive.

Prepare national systems

Every country should begin developing a national TB vaccine readiness plan.

This does not assume that any particular candidate will succeed. It ensures that countries will not be starting from zero when the evidence becomes available.

Governments must consider who should be reached first, where vaccination could take place and how new vaccines would be integrated into existing health services. Because future TB vaccines may be intended for adolescents and adults, countries cannot rely solely on systems designed for childhood immunisation.

This work must bring together national TB programmes, immunisation teams, HIV programmes, primary health care services and other relevant sectors. Health workers, data systems, supply chains and delivery infrastructure will all need to be assessed.

Communities must also be involved from the beginning.

People affected by TB, civil society and health workers understand the barriers that may prevent people from accessing services. Their participation will help governments understand community preferences, address concerns and build trust.

Public confidence cannot be created a few weeks before a vaccination programme begins.

Plan and finance together

Vaccine readiness cannot remain within ministries of health.

In Cape Town, we deliberately brought Health and Finance Committee leaders into the same room because scientific progress cannot be translated into public health impact without financing, implementation plans and accountability.

Governments need credible information about possible prices, supply timelines and the full cost of delivery. Developers and manufacturers should provide this information early enough to support realistic national planning.

Finance ministries must begin considering how vaccine introduction could be funded without weakening other essential health services. Parliaments must ask whether these discussions are taking place, scrutinise budget decisions and ensure that national plans are transparent.

We also need to move beyond country-by-country preparation.

African governments should work together to forecast demand, share information and strengthen regulatory readiness. Cooperation can reduce unnecessary duplication and help countries avoid delays once the evidence is available.

It can also give manufacturers greater confidence about future demand.

Use Africa’s collective power

The Global Fund has helped to save more than 70 million lives suffering from AIDS, tuberculosis and malaria across the globe.
An African TB clinic supported by the Global Fund. African countries need to work together to procure and roll out new TB vaccines.

African countries should not be forced to compete against one another for access to new TB vaccines. If each country negotiates alone, those with greater resources may secure earlier access while countries with the greatest need are left waiting. That would deepen existing inequalities and weaken the continent’s influence.

Governments should explore pooled procurement, coordinated demand forecasting and collective negotiations on pricing and supply. A united African approach would strengthen purchasing power, support fairer prices and reduce the risk of fragmented access.

It would also support Africa’s ambition to expand vaccine manufacturing on the continent. Sustainable manufacturing requires investment, strong regulation and predictable markets. Governments can help create those conditions by planning and purchasing together.

Global partners also have responsibilities.

Developers, manufacturers, donors and multilateral institutions should share information early, support national and regional readiness and strengthen existing health systems rather than create parallel structures that countries cannot sustain.

But they cannot replace government leadership.

Policy development, regulatory approval, budget allocation, community engagement and implementation planning remain the responsibility of national governments. Parliamentarians must hold them accountable for delivering these commitments.

At SATVI, I saw African scientists, institutions and communities helping to shape the future of TB prevention. Across the vaccine pipeline, researchers and manufacturers are preparing because they understand how much work must take place before a successful vaccine can reach people.

African political leaders must now demonstrate the same foresight.

We must work together to ensure scientific success is matched by prepared health systems, fair pricing, strong regulation and delivery plans that reach people across the continent.

The question is no longer whether African governments should prepare for new TB vaccines.

The question is whether we will act early enough to get it right.

Stephen Mutinda Mule is a Kenyan Member of Parliament and the Vice-Chair of the Global TB Caucus.

 

 

 

Image Credits: University of Cape Town, European Union.

Budget negotiations in the German Bundestag for 2027 are imminent with policymakers to clash over plans to slash global health funding amid shifting priorities.
Budget negotiations for 2027 in the German Bundestag are imminent, with policymakers set to clash over plans to further slash global health funding.

Under Germany’s tightly constrained draft budget proposal for 2027, the government is set to reduce global health funding substantially. While mandatory assessed contributions to the World Health Organization (WHO) will rise slightly, flexible budgets for pandemic preparedness are planned to be cut by 15.3%. 

As part of a broader budget overhaul, the German government is planning drastic cuts to its global health funding. While the overall draft budget for 2027 is set to expand by 5.9% to a total of €555.4 billion, driven by increased defence spending, Finance Minister Lars Klingbeil is enforcing strict fiscal discipline in other policy areas.

Consequently, the government is set to allocate significantly less funding to flexible funds for pandemic prevention than the previous year – a decision arriving in the midst of the fastest-growing Ebola outbreak ever recorded.

At the heart of proposed cuts to the Federal Ministry of Health’s (BMG) budget under the newly appointed Health Minister Carsten Linnemann is a reduction of the international health allocation by around €8.5 million (7.4%) to €106.42 million.

This affects almost exclusively the central operational fund for strengthening international public health, which Berlin is planning to slash by 15.3% to €47.33 million.

This flexible fund supports the fight against antimicrobial resistance (AMR), capacity-building in the Global South and the Joint United Nations Programme on HIV/AIDS (UNAIDS) – which is slated to receive up to €6 million, down from €6.75 million the previous year – as well as voluntary contributions to the WHO, which also support outbreak responses.

But the concrete effects of these cuts on most projects cannot be directly mapped because the majority of Germany’s support to the WHO is provided as unearmarked funding, a BMG spokesperson explained, responding to an enquiry by Health Policy Watch. Despite the cuts, the ministry emphasises that “international health security, pandemic prevention, and resilient health systems remain key priorities.”

Health Ministry defends budget plans

Germany's draft 2027 budget contrasts expanding overall federal spending with sharp cuts to international public health funding.
Germany’s draft 2027 budget contrasts expanding overall federal spending with sharp cuts to international public health funding.

The Health Ministry defended the budget draft against concerns over the funding rollbacks, underscoring that the ministry is “contributing to the demanding fiscal framework.”

A spokesperson emphasised that Germany “remains an important supporter and reliable partner of the WHO and a central actor in global health,” noting that alongside “continuing substantial funds for strengthening international public health,” its assessed contributions to the WHO are being “reliably paid” and funding for the WHO Pandemic Hub in Berlin is maintained at its existing level.

The Pandemic Hub will again receive €15 million after a cut of 50% last year. Germany’s assessed contributions to the WHO in Geneva are planned to gradually rise to around €34.39 million from €34.32 million the previous year.

Since the US’s withdrawal from WHO, the Federal Republic has become the largest government contributor.

Additionally, the draft allocates €298,000 as a mandatory contribution to the new global pandemic agreement. It also channels funds into special WHO agreements such as the Framework Convention on Tobacco Control (FCTC) (€291,000) and the Protocol to Eliminate Illicit Trade in Tobacco Products (€413,000).

The Federal Ministry for the Environment (BMUV) is also maintaining its payments to the WHO European Centre for Environment and Health in Bonn at a constant level of €3.42 million.

Contributions to Global Fund and Gavi drop slightly

Allocated through the Federal Ministry for Economic Cooperation and Development (BMZ), funding for Gavi remains at the previous year’s level of €80 million, leading to a slight decline in real terms due to inflation. Germany’s contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria falls from €288 million to €286 million.

A BMZ spokesperson defended these figures, explaining that Germany remains the second-largest government donor to both organisations. The ministry emphasised that its long-term, multi-year pledges, including €1 billion to the Global Fund for 2026–2028 and €600 million to Gavi for 2026–2030, will be “fully implemented” in 2027 with “no cuts” or changes to the agreed disbursement schedules.

Funding the central pillars of global health across different ministries follows the logic of Germany’s “whole-of-government” approach. This establishes global health as a cross-departmental priority – but in times of budgetary pressure, it leads to simultaneous adjustments across various areas of the federal budget.

Shift in geopolitical realities

Chancellor Friedrich Merz (right) and Finance Minister Lars Klingbeil (second from right) prepare to present the new budget on 8 September.
Chancellor Friedrich Merz (right) and Finance Minister Lars Klingbeil (second from right) prepare to present the new budget on 8 September.

The new draft budget cements the shift in political priorities resulting from Russia’s war of aggression in Ukraine. Under Chancellor Friedrich Merz, the federal government is taking out new loans totalling just over €118.7 billion.

However, with the majority of this borrowing headroom – €85.4 billion – earmarked for defence and security, other ministries are being forced to absorb the pressure of Germany’s constitutional debt brake. The Basic Law limits the federal structural deficit to a mere 0.35% of Gross Domestic Product (GDP), which is particularly strict in challenging economic times.

Overall, the draft subordinates international cooperation and multilateral contributions to national interests and measurable geopolitical benefits. New guidelines issued by the Federal Ministry for Economic Cooperation and Development prescribe a clear “strategic orientation towards German interests.”

The Health Ministry takes a similar approach, now strengthening bilateral partnerships abroad primarily where there is a “clear federal interest,” and aligning its global engagement with the protection of the population in Germany.

Policymakers warn against global health funding cuts

Sascha van Beek is a leading global health voice in Germany’s Bundestag (Parliament).
Sascha van Beek is a leading global health voice in Germany’s Bundestag (Parliament).

Although leading German global health politicians recognise the need to set budget priorities, they warn against the consequences of the cuts.

Sascha van Beek, a centre-right Christian Democratic Union (CDU) Member of Parliament and the rapporteur responsible for global health, argues that fiscal constraint requires smarter, more effective spending.

“The budget situation forces us to set priorities and also critically review existing expenditures for their effectiveness,” van Beek explains in response to an enquiry from Health Policy Watch.

“At the same time, I consider it wrong to view global health solely as a voluntary international commitment. Pandemic prevention, the fight against infectious diseases and antimicrobial resistance, as well as high-performing health systems in our partner countries, are in Germany’s and Europe’s direct interest.”

While continued support for the Global Fund and Gavi is important, he considers the cuts to flexible funding in particular to be risky: “We must not skimp on prevention if the next health crisis ends up costing us many times over,” van Beek explains.

His colleague on the public health committee, Serdar Yüksel – rapporteur for the centre-left Social Democratic Party (SPD) – echoes this sentiment. “It is precisely these flexible project funds that enable Germany to make a difference where help is needed quickly and in a targeted manner. Anyone who wants to strengthen the WHO must not, of all things, withdraw its flexible funds,” the health policy expert explains.

He also warns of the devastating signal sent by the gradual erosion of global alliances. Freezing contributions to organisations like Gavi or the Global Fund, causing them to lose real-terms value, directly undermines the effectiveness of life-saving partnerships on the ground, he warns.

The battle for scarce resources

SPD rapporteur Serdar Yüksel opposes global health funding cuts.
SPD rapporteur Serdar Yüksel opposes global health funding cuts.

Both health policymakers have announced their opposition to the budget plans in the imminent negotiations. Van Beek stresses that every cut must be scrutinised to determine whether it would weaken key structures for pandemic prevention.

Yüksel takes a more uncompromising stance, emphasising that the planned reductions should not be implemented.

As members of the governing parties under the federal government led by Chancellor Merz (CDU) and Finance Minister Klingbeil (SPD), both policymakers will have significant leverage in the budget negotiations.

Whether they can adjust the federal government’s priorities remains to be seen in the coming months. Following the first reading of the draft budget in the Bundestag on September 8, further debates will take place in the plenary session and in the Bundestag’s Budget Committee.

The Bundestag expects to finalise the budget in late autumn.

Image Credits: Claudia Solano via Pexels, Felix Sassmannshausen/HPW, Bundestag/Thomas Imo, Sascha van Beek/Niclas Brosthaus, Photothek Media Lab.

Fadi Jundiya, displaced Gaza resident, displays a homemade rat trap: “Every time we get rid of one rat, we find ten more.”

Nearly a year after Israel and Hamas agreed to a US-brokered cease-fire, some 94% of Gaza’s 2.1 million Palestinian residents lack adequate shelters with 84% facing severe constraints in heating, cooling, cooking, lighting and hygiene and nearly 60% facing “critical” or “catastrophic” shelter needs.  This according to a new analysis by the Global Shelter Cluster, a coalition led by the Norwegian Refugee Council and the UN’s Geneva-based International Organization for Migration (IOM).

The prolonged housing crisis means that most Gazans are being exposed to growing environmental health risks as a result of the delays in reconstruction following the two-year war. These range from poor access to hygiene and sanitation to rodent infestations; extreme heat in the summer and wintertime flooding, unsafe conditions for food and water storage; as well as toxic exposures from burning plastics and debris for cooking, the report concludes. Nearly half of all households (48%) surveyed said they burn trash to cook, with about a quarter (24%) burning plastic or tires and another 24% burning cardboard or other waste. Some 64% of households said they cannot safely store sufficient food and water.

Some 89% percent of survey respondents said they face widespread rodent infestations inside their makeshift homes. And 98% reported environmental hazards within ten meters of their residences, including solid waste, rubble or sewage.

The report is based on recent surveys of some 2000 household across Gaza. According to the report, some 54% of the surveyed households continue living in tents, an additional 11% in makeshift shelters, and the rest in buildings, often semi-destroyed during the war, while Gaza reconstruction plans advance at a snail’s pace.

Reconstruction is stymied by the continuing political impasse between Israel and Hamas as well as Israeli military restrictions, the report said. The latter forbid the entrance into Gaza of many items critical for reconstruction, including debris clearing machinery and construction equipment, pipes, rat poison, and other equipment regarded as “dual use” with the potential for military applications.

Inadequate diets and local food production stymied 

14 June 2026. A Gaza farmer carries an irrigation pipe across a field while water flows from one end. Buildings and debris are visible in the background.

While the quantity of food available in Gaza has improved due to the big influx of aid since the 10 October 2025 ceasefire, only about 3% of Gaza’s agricultural land is still usable for food production following the destruction wreaked in two years of war, a report last week by the UN Food and Agricultural Organization (FAO) noted.

Peri-urban areas around Gaza’s densely populated cities once yielded a rich array of produce – including field vegetables, fruit orchards and vineyards as well as apiaries and dairy enterprises. But most of these areas also lie near the pre-1967 border with Israel and thus were devastated along with Israel’s advances into the enclave.  Many of the same areas also remain under Israeli military control – or are otherwise unusable due to ecosystem damage, unexploded ordnance, rubble and toxic residues.a

As of 24 June 2026, 4 091 hectares – 27% of the Gaza Strip’s cropland – remained accessible to farmers, the FAO report notes. However, only about one-tenth of that, or 448 hectares, were both accessible and undamaged, according to the new geospatial assessment by FAO and the United Nations Satellite Centre (UNOSAT). Since October 2025, accessible and undamaged cropland has fallen even further — from 601 hectares to 448 hectares—a loss of 153 hectares, or 25.5 %. That is largely to Israel’s retrenchment along the “Yellow Line” dividing Israeli Defense Forces (IDF) from Hamas-controlled areas.

Results of hunger persist in developing bodies of young children

A displaced Gazan carves out a green corner to grow a few fresh vegetables in the sand amidst the debris-laden landscape of a displaced persons tent camp.

Fresh food entering the 365 square meter enclave, meanwhile, is too expensive for most Gazans to afford – leading to malnourishment among children, as well as pregnant and lactating women.

In August 2025, the Integrated Food Security Classification (IPC), a UN-backed measure of food insecurity, declared that famine was occurring in Gaza.

At the time, humanitarian access had been severely restricted since the war began in 2023. In August, 2025 alone some 17,000 children were admitted for acute malnutrition treatment at hospitals in Gaza.

Following the October 2025 ceasefire, Israel eased restrictions on the entry of humanitarian aid, which greatly increased food availability. The number of children receiving malnutrition treatment dropped to 3,000 by March 2026, and between 31 May and 15 June 2026, only around one per cent of children were still showing signs of acute malnutrition, or severe wasting.

But the long-term effects of acute hunger remain.  According to a new UNICEF survey, 12.2 per cent – one in eight children – were chronically malnourished, or stunted at the height of the hunger crisis.  Stunting can affect a child’s brain development, learning ability and future health for the rest of their lives.

Even today, “many children do not consume a diverse and balanced diet,” and “about 100,000 children and pregnant or lactating women need aid and nutritional support,” said the Humanitarian Forum, a group of Israeli NGOs in a statement last week. The statement pointed to the enclave’s near complete reliance on food aid trucked into the area as unsustainable.

And even those trucks face continuing risks as they deliver vital supplies. On Tuesday, a group of right-wing Israelis blocked aid trucks headed for Israel’s Kerem Shalom crossing into Gaza. They were protesting the planned deployment of an international force in the enclave and reconstruction efforts before Hamas is fully disarmed.

Image Credits: UNIFEED, FAO , IOM.

Patients cured of Ebola virus disease and their health workers celebrate at the Ebola Treatment Centre at Bunia General Reference Hospital.

The Democratic Republic of Congo (DRC)’s Ebola outbreak passed the 100-day mark on Monday with over 5,515 confirmed cases and 2,642 deaths – and health experts warn that the response needs to be accelerated to bring the world’s fastest Ebola outbreak under control.

While the case fatality rate is almost 48%, the DRC’s Ministry of Health reported that 1,200 people have been cured and that hospital stays are now between five and 10 days compared with the 18 to 21 days earlier in the outbreak, thanks to “improvements in technical equipment and diagnostics”.

“Laboratory capacity has expanded from one testing site to 19 laboratories capable of processing more than 3,000 samples a day,” according to the World Health Organization (WHO) Africa region.

Meanwhile, over 1,300 beds are available and over 900 health facilities have received infection prevention and control support.

New recommendations

The WHO issued a raft of new and modified recommendations on Monday to address the outbreak, following last week’s meeting of the Emergency Committee on the International Health Regulations (IHR)

The IHR are the global rules that kick in during notifiable disease outbreaks to protect all people from the international spread of disease.

Recommendations include security corridors to allow responders to reach affected communities in conflict areas; expedited customs clearance for goods needed to address the outbreak; and preventing bodies of those suspected of dying from Ebola from crossing international borders.

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, called for “scaled-up action in affected communities that is led by national, provincial and local leaders and the affected communities, sustained by needed resources and backed by committed collaboration by all partners in DRC and beyond.”

WHO Africa regional director Dr Mohamed Janabi noted that “incremental gains will not be enough. We now need to significantly step up the response: moving faster to detect cases, reaching communities sooner and strengthening operations where they are needed most”.

In the past six weeks, 60% of deaths have taken place outside Ebola treatment centres, highlighting “the persistent challenges in early detection, referral and access to treatment, while mortality among patients reaching treatment facilities may reflect late admission and severe stage of the disease”, according to a statement from WHO Africa.

Trust continues to be a barrier, with several attacks on Ebola treatment centres and health workers. The International Red Cross and Red Crescent Movement said on Monday that 12 volunteers have been injured and an ambulance set on fire in 11 violent incidents during the past 100 days.

The WHO called for the response to be “rapidly ramped up and adapted to local transmission patterns and operational gaps”, while the Africa Centres for Disease Control and Prevention has stressed a village-based approach to the outbreak to build local trust and address misinformation.

Dramatic scale-up needed

DRC Minister of Health Dr Roger Kamba (centre) receives the first consignment of the Ervebo vaccine at N’djili International Airport in Kinshasa on 21 August.

“One hundred days ago the world was warned of the Ebola Bundibugyo emergency. One hundred days later it is the fastest-growing Ebola outbreak ever recorded. Ending this emergency requires a dramatic increase in the scale and speed of the response and follow-through to put the necessary resources and tools in the hands of those on the front lines,” said Helen Clark, Co-Chair of The Independent Panel for Pandemic Preparedness and Response.

The Independent Panel noted that response efforts are being challenged by “insecurity, significant unmet humanitarian needs, the absence of basic health services, nonpayment of health workers, and low community trust”.

“We must urgently secure enough testing, build enough treatment centres to save as many people as possible, and ensure safe and dignified burials for every person who has died,” said Dr Joanne Liu, a member of The Independent Panel and former head of Médecins Sans Frontières (MSF).

“We need enough trained people to help engage with every community at risk and continued essential health services for all. If we don’t achieve this, this crisis will continue to expand,” she added.

The IPPS tracker of medical product advancements over the past 100 days.

Since the outbreak was reported, three vaccine trials for the Bundibugyo strain have started.  Over the weekend, Ervebo vaccine doses arrived – both for a phase 3 trial and for emergency use for DRC health workers.

The vaccine works against Ebola Zaire, but its effect against Bundibugyo is unknown. However, as 160 healthcare workers have been infected with Ebola and 43 have died, the DRC has been given the go-ahead to vaccinate its healthworkers with Ervebo.

Two Bundibugyo-specific tests have been given emergency use listing, and several others are undergoing trials, according to the Independent Pandemic Preparedness Secretariat (IPPS) tracker.

The PARTNERS trial is testing the efficacy of two therapeutics for Ebola Bundibugyo –MBP134 and remdesivir – and enrolled 200 participants over 14 weeks.

Medical innovation

David Reddy, Director General of the International Federation of Pharmaceutical Producers and Manufacturers and Associations (IFPMA) said that “it is clearer than ever that pandemic preparedness depends on sustained medical innovation. 

“This relies on strong partnerships, rapid access to pathogens and data, and practical solutions to the real barriers that slow outbreak response – from regulatory readiness and clinical trial capacity to financing, procurement, manufacturing, and delivery. These principles should remain at the centre of the ongoing [pathogen access and benefit-sharing] negotiations, which form a central part of the WHO Pandemic Agreement.”

Phyllis Arthur, chief of global health at the Biotechnology Innovation Organization (BIO), said that “the first 100 days of this outbreak have shown what can be possible when biotech innovators have the tools and certainty they need.”

Arthur added that “It also serves as a warning not to squander the gains made through the investment, innovation, and public-private collaboration that keep us prepared to respond to the next public health emergency. 

“Leaders negotiating the PABS system must build on this progress by establishing conditions that encourage more companies to invest in pandemic preparedness, innovation, and collaboration.”

However, the Independent Panel said that those producing medical countermeasures need to guarantee that, should the trials prove successful, these products are “widely available to those who need them in this outbreak and in future”. 

“We have learned to develop vaccines and treatments at extraordinary speed. We have not learned to guarantee they reach the people who need them. A roadmap will tell us how to make the link between a product that exists and a product that arrives,” said The Independent Panel’s Professor Michel Kazatchkine.

Image Credits: DRC Health Ministry, DRC Health Ministry, International Pandemic Preparedness Secretariat.

Doctors oversee a newborn delivered at an Islamic Development Bank-supported health facility in Banjab, Bamyan Province, Afghanistan.

Five years after the Taliban returned to power, Afghanistan’s health system is being squeezed from two directions: shrinking healthcare services and restrictions that are making it increasingly difficult for women to reach them.

The consequences are particularly acute for Afghan women. Taliban-imposed restrictions on their movement, employment and education have narrowed access to healthcare, while the December 2024 ban on women training in health and medicine has prevented new female doctors, nurses and midwives.

UNICEF has warned that Afghanistan could lose up to 5,400 female healthcare workers by 2030 if restrictions on girls’ education and women’s employment continue. As many as 9,600 health workers could be lost by 2035, the agency said.

Multiple regions ban women from being treated by male medical professionals, and women are also banned from working in humanitarian agencies,

Maternity ward massacre

Smashed doors of the MSF facility in western Kabul following the assault.

Zainab Mohammadi’s maternity experience spans two very different moments in Afghanistan’s recent healthcare history.

After seven years of trying to have a child, Mohammadi travelled from Bamiyan to Kabul in May 2020 and gave birth to a boy at the Médecins Sans Frontières (MSF) supported maternity wing of Dasht-e-Barchi hospital in west Kabul. She named him Omid, meaning “hope” in Dari. 

Gunmen stormed the maternity ward, killing 24 people, including 16 mothers, an MSF midwife and two children. MSF later said the maternity wing had been deliberately targeted, although it could not establish with certainty who carried out the attack or why.

Zainab survived, along with more than 100 people who escaped to safe rooms throughout the hospital. Her son Omid, less than half a day old, did not. “I had only four hours with my son,” she told Health Policy Watch.

MSF later said the massacre in the maternity wing had been deliberately targeted, although it could not establish with certainty who carried out the attack or why.

The assailants remain unidentified, and MSF withdrew from the maternity unit the following month, saying it could no longer put staff at risk of renewed attack. The 55-bed facility had provided free specialist maternity care and assisted almost 16,000 deliveries in 2019.

Violence to crisis

Schoolgirls in Bamozai attend classes in 2007. Today, Afghan girls are not allowed to participate in education past the second grade.

Six years later, Mohammadi’s second maternity experience illustrates a different threat to women’s healthcare: not an armed attack on a hospital, but a system in which distance, money, movement restrictions, lack of humanitarian funding and the availability of female health workers determine whether a woman receives care in time.

“Allah blessed me with a daughter last year,” Mohammadi said. “An elderly woman in our neighbourhood helped me a lot during the birth. But with many charity organisations gone and the Taliban’s restrictions on women’s freedom of movement, it has become extremely difficult for mothers like me to seek the care and support we need.”

For women like Mohammadi, the question is no longer simply whether a hospital exists. It is whether they can reach it, afford the journey and treatment, travel with a required mahram (male relative) and find an appropriately qualified female health worker when they arrive.

The attack came fifteen months before the Taliban swept back into Kabul. Six years later, Mohammadi’s second maternity experience reflects how the dangers facing Afghanistan’s women have evolved under their rule.

A mother and her child in a WHO supported maternal care facility in Bajnab, Afghanistan.

A system under financial pressure

Afghanistan’s health system was already fragile after decades of conflict, poverty and heavy dependence on international assistance. The funding crisis that intensified in 2025 has made that fragility more visible.

The World Health Organization (WHO) estimates that 14.4 million Afghans will require health assistance in 2026. Funding cuts are happening alongside food insecurity, disease outbreaks, climate shocks and large-scale returns from neighbouring countries.

Some 445 health facilities were suspended or closed during 2025, including 203 mobile health and nutrition teams, according to WHO data.

For remote communities, those mobile services were often the only practical connection to healthcare. Afghanistan’s maternal-health indicators have improved over the longer term, but the risks remain severe.

WHO and the Islamic Development Bank reported in May that the country’s maternal mortality ratio remains about 521 deaths per 100,000 live births. 

However, WHO says antenatal coverage has risen from 31% to 76% since 2007/08, while skilled birth attendance increased from 24% to 67%.

Health workers under pressure after ban on women

A Taliban Humvee rolls through Kabul’s streets after the group took control of the country in 2021.

The ban on women training as health workers comes as the country faces a shortage of 115,000 health workers to meet WHO targets for key health workers per capita. Meanwhile, women already working in healthcare face restrictions on how and where they work.

Currently, 18% of specialised physicians and 29% of nurses are female.

Shafiqa Salarzai, a female health worker in southeastern Ghazni province, travels more than 10 kilometres each day to reach women affected by the earthquake in neighbouring Paktika, providing counselling to those who lost homes, husbands and children.

“We listen to those who are traumatised,” Salarzai told Health Policy Watch. “They’ve lost everything.”

But such services are often dependent on humanitarian funding and temporary arrangements. When funding ends, the healthcare option can disappear with it. The restrictions also affect female health workers themselves.

A February 2026 report by UN Special Rapporteur Richard Bennett found that restrictions on movement, gender segregation and “mahram” requirements had severely restricted women’s access to healthcare.

Bennett documented cases in which women were denied or delayed emergency treatment because they lacked a male guardian. In one case, a woman was left to give birth outside a hospital.

The addiction treatment gap

A woman addicted to opium hides her face at a treatment centre in Mazar-i-Sharif.

The crisis extends beyond maternal and primary healthcare. Hundreds of thousands of people affected by drug addiction are also caught in Afghanistan’s fragile health system.

When the Omid drug rehabilitation centre on the outskirts of Kabul was struck in an alleged Pakistani airstrike on 16 March this year, the immediate toll was measured in casualties. But for Afghanistan’s already limited addiction-treatment system, the more serious damage is only beginning to unfold.

“This was not just a strike on a building,” said Dr Abaseen Mohammadi, a Kabul-based addiction specialist who had referred patients to the facility. “It has taken out one of the very few places in the country where people could receive structured treatment. We have nothing in the public sector to replace it.”

Details of the strike remain contested. Afghanistan’s Taliban authorities say the facility was hit during Pakistani military operations, with significant civilian casualties, including patients undergoing treatment. Rights groups have called for the strike to be investigated as a possible war crime.

United Nations figures report more than 140 deaths, while investigations continue. Pakistan has acknowledged carrying out strikes in Afghanistan in recent months but denies targeting civilian or medical infrastructure.

The Omid centre played in the country’s treatment landscape. One of Afghanistan’s largest rehabilitation facilities, it reportedly housed up to 2,000 patients at a time and functioned as a central detoxification and intake hub. Its loss has exposed the scale of the treatment gap.

According to estimates from the United Nations Office on Drugs and Crime, between three million and four million people in Afghanistan are affected by substance use. Yet fewer than one in 10 have been able to access any form of structured treatment, leaving the vast majority without sustained care.

That gap has widened since 2021, when the collapse of the former Afghan government triggered a steep decline in international health funding. Much of the country’s healthcare system has been donor-financed, and cuts to development assistance have left services, including addiction treatment, struggling to operate at even minimal capacity.

“I took my brother there because we had no other solution,” Farid, a Kabul resident whose sibling was among those killed, told Health Policy Watch. “He had stopped using it for the first time in years. Now he is gone, and there is nowhere for others like him.”

Survivors describe a sudden loss of structure and support. Without follow-up care, many face a heightened risk of relapse in a context where community-based services are scarce, and stigma remains high.

“Substance use treatment is chronically underfunded, even where the need is enormous,” said an MSF regional officer. “When a facility like this is lost, there is no rapid replacement. The gap can persist for years.”

As Afghanistan enters the sixth year of Taliban rule, the country’s healthcare crisis is about more than the number of clinics that have closed or services that have been cut. It is also about who can reach those services, who can provide them and whether there will be enough trained health workers to sustain them.

The most consequential legacy of Taliban rule on the country’s health sector may therefore be not only what has already been lost, but the female healthcare workforce that is no longer being allowed to replace it.

Image Credits: WHO EMRO, MSF, CC, WHO, CC, Jacksoncam.

Doctors lit a fire outside the Ebola Treatment Centre in Ituri province to protest delayed payment. As they put themselves at risk of Ebola by treating patients without pay, violence against health workers from local communities is mounting. 

Twelve Red Cross volunteers have been injured and an ambulance set on fire in 11 violent incidents during the 100 days since the Democratic Republic of Congo (DRC) declared its Ebola outbreak, the International Red Cross and Red Crescent Movement said Monday.

Three volunteers taking part in response activities were attacked and injured by a group of individuals in Beni, North Kivu province, on 19 August, according to the statement, issued jointly by the Red Cross societies of the DRC and Uganda, the International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Committee of the Red Cross (ICRC).

“Attacks against volunteers and humanitarian personnel are unacceptable,” the Movement said, warning that every injured responder and damaged ambulance “reduces the capacity to provide emergency health and humanitarian services, putting more lives at risk and making the epidemic harder to contain.”

The deadliest Ebola outbreak for health workers, DRC’s 2018–2020 Ebola epidemic, saw more than 25 health workers killed in attacks over two years.

A day earlier, two volunteers were injured while attempting to conduct a safe and dignified burial – the practice of trained teams in protective gear burying the highly contagious remains of Ebola victims – in the village of Malikuti in Haut-Uélé province, and were evacuated to Isiro for medical care. This burial practice, while protecting communities from infection, denies families the chance to touch their lost loved ones, rites central to funerals in much of the region, making the restrictions a major source of anger toward response teams.

On 17 August, a Ugandan Red Cross convoy supporting the cross-border response was attacked in Aru, Ituri province, leaving one team member seriously injured and two ambulances pelted with stones and vandalised.

“These attacks serve as an alarming reminder of the risks faced by humanitarian workers and volunteers engaged in the fight against epidemics and emergencies,” the IFRC added. “Respect for humanitarian personnel and humanitarian activities is essential to ensuring that communities affected by epidemics and other crises continue to receive the assistance and services they urgently need.”

Attacks on health escalate

Each square represents a health worker infected by Ebola since the outbreak began in May. Over 40 have already died.

More than 260 attacks on health workers have been recorded in the DRC over the past six months, and eight health workers have been killed, UN Senior Ebola Coordinator Julien Harneis told reporters from Bunia on Friday.

“When we do respond, apart from the threat from the virus, healthcare workers and frontline workers have been attacked by youths, ambulances have been burned and stoned, and the healthcare facilities have been attacked,” Harneis said, “which is obviously terrifying because people are already risking their lives to deal with Ebola.”

Another 160 healthcare workers have been infected with Ebola, of which 43 have died. Many have not been fully paid for their life-endangering work as the health ministry and international community struggle to marshal funds to the response’s frontlines.

“Almost on a daily basis we face some kind of reaction from the communities,” Dr Thierno Baldé, the World Health Organization’s (WHO) incident manager for the response, said last week, a day after another ambulance was attacked. “These are difficult situations. People are having their relatives who are sick, who are dying.”

Attack on Ebola Hospital in Eastern Congo Echoes Past Violence Against Health Workers

Some 5,290 people have been infected, and 2,516 have died since the outbreak was declared on 15 May, according to health ministry figures published Friday.

The epidemic, driven by the Bundibugyo species of the virus for which no licensed vaccine or treatment exists, is the fastest-growing Ebola outbreak on record and the deadliest in the DRC’s history, with a case fatality rate of 47.6%.

Africa CDC warned last week that the outbreak may be three times its officially reported size, with only 30-40% of cases detected.

“The epidemic is spreading to an area that is bigger than France,” Harneis said. “And the outbreak is growing faster and wider than the Ebola response. And all of this is happening in an area that has ​had ​three decades of conflict and is generating huge humanitarian ​needs.”

Attacks on responders during the DRC’s 2018-2020 Ebola epidemic, previously the country’s deadliest, killed more than 25 health workers.

Image Credits: Anicet Kimonyo.

Indonesia's Health Minister Budi Gunadi Sadikin was nominated as candidate for the WHO DG election
Indonesia’s Health Minister Budi Gunadi Sadikin was nominated as candidate for the WHO DG election.

Indonesia has officially nominated its Health Minister, Budi Gunadi Sadikin, for the WHO Director-General election – in what is also an unconventional candidacy for the global health agency that has traditionally been led by medical or public health professionals. Sadikin was posted as an official nominee on the WHO election website over the weekend.

Sadikin was officially listed as prospective candidate over the weekend.
Sadikin was officially listed as prospective candidate on the WHO website over the weekend.

A nuclear physicist and banker by training, Sadikin took over the Indonesian Ministry of Health in December 2020, leading the country through the COVID-19 pandemic without any formal medical or public health background.

“And then suddenly the previous president put me [in charge] as the first health minister … to take care of COVID,” Sadikin remarked at an event on pandemic preparedness on the sidelines of the World Health Assembly.

Prior to his service as health minister, he built a corporate track record as the Chief Executive Officer of Indonesia’s largest Bank Mandiri, starting in 2013. He later served as Group CEO of the state-owned mining and aluminium enterprise PT Inalum until 2019.

Corporate leadership in a time of institutional crisis

Indonesia contributed some $30 million to WHO in voluntary funding last month to help close the outstanding funding gap.
Indonesia contributed some $30 million to WHO in voluntary funding last month to help close the outstanding funding gap.
WHO Director General Dr Tedros Adhanom Ghebreyesus shakes hand of Indonesian Health Minister outside WHO headquarters on 1 July 2026, after Indonesia pledged an additional $30 million to fund WHO.

Sadikin’s lack of medical or public health training is seen as a disadvantage by some observers. By contrast, all previous Director-Generals – with the sole exception of Dr Tedros Adhanom Ghebreyesus – were qualified medical doctors. Tedros holds an MSc in infectious diseases from the University of London.

However, Sadikin’s strong background in finance could arguably be a decisive advantage in the current climate.

As a key diplomatic credential, he is also one of the architects of the World Bank-hosted Pandemic Fund, launched in Bali in 2022.

While Tedros has not openly endorsed any DG candidate, he posted a flattering thanks to Sadikin on LinkedIn last month after Indonesia contributed some $30 million to WHO in voluntary funding to help close the outstanding funding gap in the agency’s 2026-27 $4.2 billion base programme budget. As of May, the budget remained short of $300 million in funding – even after its originally proposed 2026-27 base budget was pared back by over $1.1 billion since the United States withdrew from the global health agency in January 2025.

Fourth contender in the race

Sadikin’s nomination brings the current field to four declared contenders ahead of the 24 September deadline, along with Dr Hanan Balkhy of Saudi Arabia and Dr Hanan Mohammed Al-Kuwari of Qatar. Last week, Belgium’s Dr Hans Kluge announced his candidacy.

The declared candidates so far, also are informally regarded as the current “frontrunners” in the election, scheduled for May 2027 in Geneva. Just one month remains for new contenders or dark horses to emerge before nominations close on 24 September. 

The upcoming election comes at a time of tumult and change within the WHO. Funding shortfalls triggered by the United States’ withdrawal from the global health agency have forced far-reaching cost-cutting measures – reducing staff by 25% over the past year.

And over the past month, several members of the senior leadership team have left the organization – including the leading UK physician and researcher Dr Jeremy Farrar, whose departure was confirmed only last week. Farrar had also been considered a potential DG candidate but he has denied that he is running – however he has also remained mum on his future plans.  

Member States will elect the new leader during the 80th World Health Assembly. The successor will assume office on 16 August 2027, immediately after Dr Tedros Adhanom Ghebreyesus concludes his term.

See related story:

https://healthpolicy-watch.news/high-profile-departures-who-leadership/

Image Credits: Tedros Adhanom Ghebreyesus, Felix Sassmannshausen/HPW.

8th India Clean Air Summit in Bangalore, which ended Friday.

As Delhi’s officials finally take tough action on major pollution sources, the demand for a similar approach is rising in other states – as seen at the 8th Indian Clean Air Summit held this week in Bangalore. 

BANGALORE, INDIA – Two decades ago, authorities in Delhi switched public and heavy duty transport from largely diesel to compressed natural gas (CNG), then seen as a cleaner fossil fuel.

Electric bus in India
Like buses, light duty CNG trucks will now give way to EVs.

But on Thursday, Delhi officials blamed light-duty CNG trucks, the kind used in courier services or urban deliveries, as one of the persistent drivers behind Delhi’s notorious air pollution  – announcing a major initiative to phase out 150,000 CNG light duty trucks, as well as diesel vehicles. The ban on registration of new light-duty CNG vehicles is due to begin in January 2027 in the city extending to suburban areas in July. The move to phase out the trucks follows a policy of swapping out CNG passenger buses for electric ones, underway already for several years. 

“We’re transitioning to total clean fuel,” said Tarun Pithode, Member Secretary of the Commission for Air Quality Management in a press conference – referring to the switch to electric vehicles, in particular.

While CNG fuel is lower in particulate matter, “oxides of nitrogen (NOx) from CNG are leading to a lot of pollution, especially secondary particulate matter. The haze happens when NOx and ozone mix,” Pithode explained. 

Even if they meet current Indian emission standards, (Bharat Stage 6 – roughly equivalent to a Euro 6 vehicle), CNG light duty trucks emit more than 57 times PM2.5, while BS 6 diesel light trucks emit approximately 130 times more, officials said.

Light goods vehicles by fuel type across the Delhi region. Data source: Indian Commission for Air Quality Management

Demand rises for Delhi-like airshed approach

Neeraj Naryan and Sharlene Chichgar at the 8th India Clean Air Summit.

While Delhi’s airshed officials are finally taking significant steps, the demand for a similar airshed approach is rising in other states. That was the main message at the 8th India Clean Air Summit in Bangalore this week. 

Speaking at the event, Neeraj Narayan, a top pollution control official from the eastern Indian state of Bihar said, “the airshed methodology must be accepted by all.” 

Only a few of the 131 cities that were part of the 2019 National Clean Air Programme (NCAP) have so far achieved the targeted reductions in air pollution, pointed out Narayan, Member Secretary of Bihar’s Pollution Control Board. 

The programme aimed for a 40% reduction in PM10 particulate concentrations by 2025-2026, and/or meeting the Indian air quality standard of 60 micrograms of PM10 for one cubic meter of air (60 µg/m³). That is something only 23 out of the original cities attained, according to a 2026 progress review by the Center for Research on Energy and Clean Air.  And in fact, while data was tracked for 130 cities a larger pool of some 1,787 Indian cities persistently fail to attain Indian air quality standards, the CREA report stated.

Some 1,787 Indian cities fail to meet national national air quality standards.

“Do we have this much time?” he added. Bihar is one of India’s most polluted states.

Dr Ratish Menon.

Meanwhile, Dr Ratish Menon,  Narayan’s counterpart from Kerala, a coastal state considered an idyllic tourist destination, echoed his remarks. And much of the state’s air pollution comes from neighboring regions, he underlined. 

In the case of Kerala, “the larger chunk is sent from (neighbouring) Tamil Nadu,” Menon said, making the case for strategies to combat air pollution at the level of “airsheds” whose borders cross multiple states.

World Bank’s $750 million clean air initiative in India 

The call for an airshed approach was echoed by the World Bank representative, Sharlene Chichgar, at the conference. 

While the legal framework for the National Commission for Air Quality Management (CAQM) has been strengthened, it needs to have “much more enforcement powers,” she said.

In July, the World Bank announced a major finance initiative of $150 million to support Delhi’s new clean air measures, which included a major air pollution initiative in April, followed by a new $1.5 billion policy to promote  EV three-wheelers, cars and buses in July.   See related story: 

Can Delhi’s $2.5 Billion Shift to Electric and Low-Emission Vehicles Transform India’s Capital to a ‘Pollution Free City’?

That followed World Bank finance initiatives late last year of $300 million each for Uttar Pradesh and Haryana, two highly polluted states that border on, and in some places overlap with, the national capital region.  

The Uttar Pradesh programme will help 3.9 million households gain access to clean cooking and support a transition to clean transport by introducing 15,000 electric three-wheelers, and 500 electric buses in the cities of Lucknow, Kanpur, Varanasi, and Gorakhpur. The project also will support Uttar Pradesh state government plans to provide incentives to replace 13,500 polluting heavy-duty freight vehicles with lower emitting vehicles. 

The Haryana project will invest in air quality and emission monitoring systems to  better assess critical pollution sources. The project will also support investments in electric buses and three wheelers in the cities of Gurugram, Sonipat, and Faridabad, with better transport connections and job access – especially for women. The project will also support new no-burn technologies to manage agriculture waste management, and productive reuse of paddy stubble. Smoke from burning crop waste in Haryana and other neighboring states regularly cloaks the Delhi region in haze in the late autumn.  

Farmers burn stubble burning on 3 November 2025, at Tohana, Haryana.

While progress is being made, Chichgar called for a “stronger horizontal and vertical coordination of government” across departments and agencies, and between cities, states and the central government. 

She also emphasized the “need to work on data transparency, a lot in terms of how we share data with citizens, and also have more public awareness and audits on what is done on pollution, how is performing, and where the government needs to work harder.

“We need a committed executive, which puts a vision forward over the next 15, 20 years on air quality management… and puts in place the financing framework,” Chichgar said.

Air pollution politics

Air pollution has increasingly become a featured topic of conversation amongst  political and policy commentators and on social media along with other challenges of governance. One such recent post, for instance, highlighted the lack of government accountability for chronic air pollution along with other recent scandals including medical school entrance exam leaks, urban flooding, and corruption. 

Another columnist writing during last year’s peak winter pollution season, demanded a political debate on the Air Quality Index (AQI). 

Change is in the air  

Jai Asundi – sees progress in political prominence of air quality issues.

So has anything changed despite India dominating the world air quality rankings of the most polluted cities for years? 

The hosts of Indian Clean Air Summit, are well placed to assess that. The first Summit, which attracts a high-level group of scientists, researchers, entrepreneurs, policy experts and government officials, took place in 2018 just before India’s first National Clean Air Programme was launched.

Over the last eight years there has been a shift from treating air pollution primarily as an environmental issue to recognising it as a cross-sectoral development challenge, says Jai Asundi, Executive Director at the Center for the Study of Science, Technology and Policy. And that, he sees, is progress.

The fact that it is increasingly clubbed together with other political challenges doesn’t mean air pollution is being politicised, he said. In fact, what has changed most noticeably is the quality of the conversation reflecting a much higher level of greater knowledge. 

Air pollution appearing in mainstream public discourse is therefore not necessarily a case of politicisation — it can also indicate that the issue has moved from a purely environmental sector concern to a broader public-policy and development concern. The next challenge is to convert that awareness and better evidence into sustained, measurable reductions in exposure.”

Image Credits: Chetan Bhattacharji/HPW, CAQM – Commission for air quality management, Centre for Research on Energy and Clean Air , Vidyut Mohan, Chetan Bhattacharji.

Health workers in the DRC put together protective gear during an Ebola outbreak in 2019.

Over 5,000 people have been infected with the Ebola Bundibugyo virus in the Democratic Republic of Congo (DRC), but the outbreak may be three times the officially reported size, warned the Africa Centre for Disease Control and Prevention has said.

Speaking at a press briefing, Africa CDC’s Prof Yap Boum said the estimation of various experts and academics, is that “only 30-40% of cases” are in fact being detected and reported.

Part of the reason is that the symptoms for Bundibugyo are milder than Ebola Zaire and “you don’t have the bleeding”, which makes it harder to distinguish from other illnesses, he added.

Boum also noted that the vast majority of deaths – 97% in the past week – were still taking place in the “community” – although he clarified that the definition includes health facilities that were not Ebola treatment centres.

Once again, the Africa CDC highlighted the weakness in contact tracing, with only around 16% of contacts with confirmed Ebola cases having been traced.

Spread to DRC regions near Central African Republic an emerging concern

Boum also sounded the alarm about new cases detected in the DRC provinces of Haut-Uélé and Bas-Uélé, which border the Central African Republic (CAR). Two cases have now been detected in the Bas-Uélé capital of Buta, about 200km from the CAR border.

Last week, the World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus and Africa CDC leaders met in CAR, which has also been wracked by years of conflict, to assist the country to prepare for Ebola in case it moved across the border.

Measures include increased surveillance at checkpoints and borders, and bolstering laboratories.

Ervebo vaccines to be trialled in DRC against Bundibugyo virus strain

Meanwhile, the DRC and international partners as preparing to conduct a clinical trial testing the efficacy of the Ervebo vaccine against the Zaire ebolavirus strain against Bundibugyo in amongst groups of health workers deemed to be at highest risk, WHO said on Thursday.

This followed an agreement with the International Coordinating Group on Vaccine Provision (ICG) to send 70,000 doses of Ervebo vaccines to the DRC, at the government’s. The ICG manages the vaccine stockpile in partnership with WHO, the International Federation of the Red Cross and Red Crescent, Médecins Sans Frontières and UNICEF. Gavi, the Vaccine Alliance, provides funding for the stockpile.

 

While Ervebo is only licensed and recommended for use against the Zaire ebolavirus strain, early laboratory and animal data suggest it may provide some protection, WHO said.

The allocation includes 20,000 doses for the Phase 3 of this trial, and 50,000 doses are for frontline health workers, in line with the current recommendations of the WHO Strategic Advisory Group of Experts on Immunization (SAGE).

Two other vaccine candidates, ChAdOx1, and Moderna’s mRNA vaccine, are currently recruiting patients in the DRC for early trials.

Image Credits: John Wessels/ MSF.

Hans Henri Kluge, the WHO/Europe Regional Director, at a meeting of WHO’s European Regional Committee (member states) in December 2025.

Dr Hans Henri Kluge, WHO’s Regional Director for Europe, has become the third candidate to throw his hat into the ring in the race for the next WHO Director-General. He will be taking a leave of absence from his duties from Friday, 21 August 2026 following his nomination by home country Belgium. This is according to an internal email by Dr Tedros Adhanom Ghebreyesus to WHO staff, seen by Health Policy Watch.

Kluge is also the second Regional Director, after Dr Hanan Balkhy, to temporarily step down from office under new guidelines issued by Tedros earlier in July.

The guidelines require WHO Regional Directors to step back from the posts and go on special leave at half pay if they enter the leadership campaign – despite the fact that RD’s are elected by member states. This rule aims to level the playing field with other internal WHO candidates who were already required to take leave in previous races.

Kluge had not responded to an earlier enquiry from Health Policy Watch regarding his possible candidacy. Tedros, however, made it clear in his message today:

“Dear colleagues, I am writing to inform you that Dr Hans Kluge, Regional Director for Europe, will take leave from his WHO functions effective 21 August 2026, in connection with his candidature for the position of Director-General of the World Health Organization,” the DG said in the internal mail sent just before 6 p.m. Thursday evening.

On Friday, Kluge confirmed his nomination in a LinkedIn post. “The Government of Belgium has nominated me for the position of WHO Director-General. I am deeply honoured by the trust and confidence Belgium has placed in me, and grateful for the opportunity to stand for this important responsibility,” the post read.

European Director of Programme Management takes charge

To ensure continuity in the European Region, Dr Corinne Capuano will take over as Officer-in-Charge on an interim basis, the WHO Director General added.

“I am grateful to Dr Capuano for assuming these responsibilities and confident that, with the support of colleagues across the Region and the Organisation, WHO’s vital work will continue without interruption,” said Tedros in the internal communication.

Capuano has been Director of Programme Management in Europe since February 2025.

Kluge, a Belgian physician, has led WHO’s European Region since February 2020 – through the COVID-19 pandemic, a subsequent mpox outbreak, and the cascading fallout of Russia’s war in Ukraine on health systems both in Ukraine and beyond.

The current field of candidates so far

Kluge’s declaration means that three candidates are now in the race. The other two candidates are listed as contenders on the organisation’s website are: Dr Hanan Mohammed Al-Kuwari (nominated by Qatar) and Dr Hanan Balkhy (nominated by Saudi Arabia).  But the list is expected to grow further before the final deadline for official nominations, set for 24 September. Indonesia’Minister of Health Budi Gunadi Sadikin is considered likely to enter the race.

Other figures around which speculation has centered have included Sania Nishtar, currently CEO of Gavi, The Vaccine Alliance and Helge Braun, a German physician and politician associated with the Christian Democratic Party – led for many years by former Chancellor Angela Merkel. Former French Health Minister Agnès Buzyn  has also been named as a possible candidate.

Several other high-profile figures whose names previously had been mentioned as potential candidates have recently said they would not run for the DG’s office. Dr Jarbas Barbosa, Regional Director of the Pan American Health Organisation (PAHO), ruled out standing for the race, saying that he wanted to focus on leading the Americas region, which faces its own financial troubles since funding from the United States, PAHO’s biggest donor, has become uncertain.  The noted British scientist Dr Jeremy Farrar, also has said he had “no intention” of standing for the top post – even though on Monday his resignation as Assistant Director-General Health Promotion, Disease Prevention and Care was abruptly confirmed by WHO, effective September.

While WHO claimed that Farrar, age 64, is retiring, several other sources claimed he had resigned – signaling potential dissatisfaction or a reluctance to continue being associated with Tedros’ administration in its waning days. Farrar has not publicly commented on his next moves.

Following the formal submission of DG nominations, the official timetable sets out two key dates prior to the final decision: the first candidates’ forum will begin on 18 November 2026, followed by the Executive Board narrowing the field of candidates down to a maximum of three finalists during its 160th session from 25 January to 2 February 2027.

The election by the Member States is due in May 2027 during the 80th World Health Assembly. The successor will take office on 16 August 2027, immediately after Tedros’s term ends.

See related story:

Want to Become the Next WHO Director-General? Get in Line 

Editorial note: The piece has been update on 21 August to reflect Kluge’s social media post.

Image Credits: WHO/Christopher Black , WHO/Europe .